To further verify the expression level of signature genes in DLBCL, we performed qRT-PCR on our clinical samples to quantify the mRNA expression of these four genes (TUBB4A, SLC38A5, S100B, and TEX9). This evidence concerns the gene TEX9 and diffuse large B-cell lymphoma.